Detalhe da pesquisa
1.
Immune checkpoint therapy-current perspectives and future directions.
Cell
; 186(8): 1652-1669, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059068
2.
Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events.
J Natl Compr Canc Netw
; : 1-8, 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190801
3.
Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer.
Curr Treat Options Oncol
; 25(1): 66-83, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212510
4.
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
J Neurooncol
; 153(3): 441-446, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34076832
5.
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer.
Curr Treat Options Oncol
; 25(5): 617-618, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642282
6.
Cell shape change and invagination of the cephalic furrow involves reorganization of F-actin.
Dev Biol
; 402(2): 192-207, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25929228
7.
Molecular pathways and cellular subsets associated with adverse clinical outcomes in overlapping immune-related myocarditis and myositis.
Cancer Immunol Res
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768394
8.
Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors.
J Cancer Res Clin Oncol
; 149(8): 5429-5436, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36451045
9.
Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer.
Endocrinology
; 164(6)2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192413
10.
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor).
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948506
11.
Anti-PD-L1 plus enzalutamide does not improve overall survival in prostate cancer.
Cell Rep Med
; 3(4): 100613, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35492243
12.
A composite T cell biomarker in pre-treatment blood samples correlates with detection of immune-related adverse events.
Cancer Cell
; 40(3): 249-251, 2022 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290784
13.
Schistosomiasis vaccines.
Hum Vaccin
; 7(11): 1192-7, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22048120
14.
The Next Decade of Immune Checkpoint Therapy.
Cancer Discov
; 11(4): 838-857, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811120
15.
Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy.
Eur J Heart Fail
; 23(10): 1725-1735, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34114291
16.
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663638
17.
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors.
JAMA Netw Open
; 4(8): e2122998, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459906
18.
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34326169
19.
Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment.
Transl Androl Urol
; 9(Suppl 1): S56-S65, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32055486
20.
EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture Fixation.
Pain Res Manag
; 2020: 5982567, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32774566